homopolymeric captopril (PharmaPatents Global)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehomopolymeric captopril (PharmaPatents Global)
Drug Alias Namehomopolymeric captoprilcaptopril (homopolymeric)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCollagen modulatorsAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzymeCollagen
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaPatents Global Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaPatents Global Ltd
Active IndicationsN/A
Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A
Related LinksN/A